The aim of this study was to assess whether the transition from cTnI to hs-cTnT has led to disparities in identifying AF patients who benefit from CA and to identify additional factors that may predict the need for revascularization among AF patients. The gene discussed is TNNT2; the disease is atrial fibrillation.